Results 141 to 150 of about 2,402 (195)

Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice. [PDF]

Proc Natl Acad Sci U S A, 2017
Camporez JP, Wang Y, Faarkrog K, Chukijrungroat N, Petersen KF, Shulman GI.   +5 more
europepmc   +1 more source

Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers. [PDF]

Biomed Res Int, 2013
Khlifi R, Messaoud O, Rebai A, Hamza-Chaffai A.   +3 more
europepmc   +1 more source

Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine. [PDF]

BMC Pharmacol Toxicol, 2014
Hou ZD, Xiao ZY, Gong Y, Zhang YP, Zeng QY.   +4 more
europepmc   +1 more source

Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. [PDF]

BMC Cancer, 2014
Endo Y, Yamashita H, Takahashi S, Sato S, Yoshimoto N, Asano T, Hato Y, Dong Y, Fujii Y, Toyama T.   +9 more
europepmc   +1 more source

Structural and biochemical characterization of an active arylamine N-acetyltransferase possessing a non-canonical Cys-His-Glu catalytic triad. [PDF]

J Biol Chem, 2013
Kubiak X, Li de la Sierra-Gallay I, Chaffotte AF, Pluvinage B, Weber P, Haouz A, Dupret JM, Rodrigues-Lima F.   +7 more
europepmc   +1 more source

Impact of <i>N</i>-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine. [PDF]

Biomolecules
Habil MR, Stephens MA, Cass AA, Mittlestat EM, Kwon D, Ellison A, Kouokam JC, Hein DW.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Arylamine N-acetyltransferase I

International Journal of Biochemistry and Cell Biology, 2007
Arylamine N-acetyltransferase I (NAT1) is a phase II enzyme that acetylates a wide range of arylamine and hydrazine substrates. The NAT1 gene is located on chromosome 8 and shares homology to NAT genes found in most mammalian species. Gene expression occurs from at least two promoters and a number of tissue-specific transcripts have been identified ...
Carston Wagner, Neville Butcher, Rodney Minchin   +2 more
exaly   +6 more sources

Arylamine N-acetyltransferase in human red blood cells

Biochemical Pharmacology, 1992
N-Acetyltransferase activities associated with erythrocytes from 20 individuals have been determined with p-aminobenzoic acid as substrate. A three-fold variation in Vmax is found. The N-acetyltransferase genotype of the individuals has been determined and there is no correlation between the extent of acetylation measured in the individuals ...
Edith Sim, Alison Ward, D Hickman
exaly   +3 more sources

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2 [PDF]

Bioorganic and Medicinal Chemistry, 2009
The identification, synthesis and evaluation of a series of rhodanine and thiazolidin-2,4-dione derivatives as selective inhibitors of human arylamine N-acetyltransferase 1 and mouse arylamine N-acetyltransferase 2 is described.
Edith Sim, Edward Lowe, Nicola Laurieri   +2 more
exaly   +2 more sources

Evidence for two closely related isozymes of arylamine N -acetyltransferase in human liver [PDF]

FEBS Letters, 1989
Acetyl CoA-dependent arylamine N-acetyltransferase (EC 2.3.1.5) is the target of a genetic polymorphism in the metabolism of drugs and carcinogens. N-Acetyltransferase was purified 1000-fold from cytosol of human liver and its identity was verified by ...
Denis Grant, Urs A Meyer
exaly   +2 more sources